J. Scott Garland - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 165,766 shares made by Richard A. Paulson , a net sale of 55,214 shares made by Michael Mason , and a net sale of 34,041 shares made by Stuart Poulton .

In summary, during the past 3 months, insiders sold 10,902 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 10,902 shares. During the past 18 months, 2,075,796 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 2,034,656 shares.

Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Relypsa Inc (RLYP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Relypsa Inc (RLYP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Relypsa Inc (RLYP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in Exelixis Inc (EXEL). Other recent insider transactions involving Exelixis Inc (EXEL) include a net sale of 390,710 shares made by Jeffrey Hessekiel , a net sale of 207,310 shares made by Patrick J. Haley , and a net sale of 218,631 shares made by Dana Aftab .

In summary, during the past 3 months, insiders sold 314,736 shares of Exelixis Inc (EXEL) in total and bought 0 shares, with a net sale of 314,736 shares. During the past 18 months, 1,342,853 shares of Exelixis Inc (EXEL) were sold and 735,409 shares were bought by its insiders, resulting in a net sale of 607,444 shares.

Exelixis Inc (EXEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 240,340 shares made by Samuel C. Blackman , a net sale of 122,037 shares made by Jeremy Bender , and a net sale of 72,915 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 88,527 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 88,527 shares. During the past 18 months, 463,467 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 1,475,454 shares were bought by its insiders, resulting in a net purchase of 1,011,987 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 145,903 shares made by Jaume Pons , a net sale of 14,288 shares made by Shelly Pinto , and a net sale of 18,243 shares made by Sophia Randolph .

In summary, during the past 3 months, insiders sold 0 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 30,000 shares, with a net purchase of 30,000 shares. During the past 18 months, 179,321 shares of ALX Oncology Holdings Inc (ALXO) were sold and 58,400 shares were bought by its insiders, resulting in a net sale of 120,921 shares.

ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, J. Scott Garland made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 334,574 shares made by Cyrus Harmon , a net sale of 2,410,761 shares made by G. Walmsley Graham , and a net sale of 70,436 shares made by David C. Myles .

In summary, during the past 3 months, insiders sold 1,616,447 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 700,761 shares, with a net sale of 915,686 shares. During the past 18 months, 6,819,521 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,946,693 shares were bought by its insiders, resulting in a net sale of 3,872,828 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.